BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7761276)

  • 1. [Immunoscintigraphy of bone marrow in plasmacytoma].
    Bathmann J; Brugger W; Ullrich C; Mertelsmann R; Moser E
    Nuklearmedizin; 1995 Apr; 34(2):66-70. PubMed ID: 7761276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoscintigraphy of the bone marrow: normal uptake values of technetium-99m-labeled monoclonal antigranulocyte antibodies.
    Huić D; Ivancević V; Richter WS; Munz DL
    J Nucl Med; 1997 Nov; 38(11):1755-8. PubMed ID: 9374347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
    Ivancevic V; Huic D; Wolter A; Munz DL
    Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders.
    Chung JK; Yeo J; Lee DS; Park S; Lee MC; Kim BK; Koh CS
    J Nucl Med; 1996 Jun; 37(6):978-82. PubMed ID: 8683326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
    Krause T; Reinhardt M; Nitzsche E; Moser E
    Nuklearmedizin; 1999 Apr; 38(3):85-9. PubMed ID: 10320994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
    Krause T; Eisenmann N; Reinhardt M; Bathmann J; Altehoefer C; Finke J; Moser E
    Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
    Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
    Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
    J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow imaging in plasma cell dyscrasias: review of 130 cases.
    Feggi LM; Scutellari PN; Prandini N; Orzincolo C; Spanedda R
    J Nucl Biol Med (1991); 1992; 36(4):303-8. PubMed ID: 1296769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosis.
    Thelen MH; Eschmann SM; Moll-Kotowski M; Dopfer R; Bares R
    J Nucl Med; 1998 Jun; 39(6):1033-5. PubMed ID: 9627340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody.
    Choi CW; Chung JK; Lee DS; Lee MC; Chung HK; Kim BK; Koh CS
    Nucl Med Biol; 1995 Jan; 22(1):117-23. PubMed ID: 7735161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserve.
    Matthies A; Reinhardt M; Palmedo H; Ezziddin S; Abramowski B; Kuhn W; Biersack HJ; von Mallek D
    Cancer Invest; 2005; 23(2):119-22. PubMed ID: 15813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
    Zoeller G; Sandrock D; Munz DL; Ringert RH
    Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic hematopoietic bone marrow in the appendicular skeleton after trauma.
    Kaim A; Ochsner P; Maurer T; Jundt G; Mueller-Brand J
    J Nucl Med; 1998 Nov; 39(11):1980-3. PubMed ID: 9829593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow scintigraphy. Principles, clinical results and indications].
    Munz DL
    Radiologe; 1992 Oct; 32(10):485-94. PubMed ID: 1438717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
    Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
    Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
    Bathmann J; Moser E
    Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases.
    Reske S; Kartsens J; Sohn M; Glöckner W; Buell U
    Acta Oncol; 1993; 32(7-8):753-61. PubMed ID: 8305223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow].
    Reske SN; Karstens JH; Henrich MM; Sohn M; Glöckner W; Jakse G; Büll U
    Nuklearmedizin; 1993 Jun; 32(3):111-9. PubMed ID: 8327329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99Tcm-LL1: a potential new bone marrow imaging agent.
    Juweid M; Dunn RM; Sharkey RM; Rubin AD; Hansen HJ; Goldenberg DM
    Nucl Med Commun; 1997 Feb; 18(2):142-8. PubMed ID: 9076770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.